1. Home
  2. TVTX vs TRIP Comparison

TVTX vs TRIP Comparison

Compare TVTX & TRIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • TRIP
  • Stock Information
  • Founded
  • TVTX 2008
  • TRIP 2000
  • Country
  • TVTX United States
  • TRIP United States
  • Employees
  • TVTX N/A
  • TRIP N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • TRIP Computer Software: Programming Data Processing
  • Sector
  • TVTX Health Care
  • TRIP Technology
  • Exchange
  • TVTX Nasdaq
  • TRIP Nasdaq
  • Market Cap
  • TVTX 1.9B
  • TRIP 2.0B
  • IPO Year
  • TVTX N/A
  • TRIP 2011
  • Fundamental
  • Price
  • TVTX $17.44
  • TRIP $14.03
  • Analyst Decision
  • TVTX Strong Buy
  • TRIP Hold
  • Analyst Count
  • TVTX 13
  • TRIP 14
  • Target Price
  • TVTX $33.08
  • TRIP $17.86
  • AVG Volume (30 Days)
  • TVTX 1.5M
  • TRIP 3.0M
  • Earning Date
  • TVTX 05-05-2025
  • TRIP 05-07-2025
  • Dividend Yield
  • TVTX N/A
  • TRIP N/A
  • EPS Growth
  • TVTX N/A
  • TRIP N/A
  • EPS
  • TVTX N/A
  • TRIP 0.04
  • Revenue
  • TVTX $233,175,000.00
  • TRIP $1,835,000,000.00
  • Revenue This Year
  • TVTX $71.39
  • TRIP $7.63
  • Revenue Next Year
  • TVTX $55.24
  • TRIP $7.14
  • P/E Ratio
  • TVTX N/A
  • TRIP $390.68
  • Revenue Growth
  • TVTX 60.55
  • TRIP 2.63
  • 52 Week Low
  • TVTX $5.12
  • TRIP $12.93
  • 52 Week High
  • TVTX $25.29
  • TRIP $28.15
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 34.91
  • TRIP 40.43
  • Support Level
  • TVTX $20.29
  • TRIP $13.39
  • Resistance Level
  • TVTX $20.98
  • TRIP $15.46
  • Average True Range (ATR)
  • TVTX 1.00
  • TRIP 0.50
  • MACD
  • TVTX -0.23
  • TRIP 0.04
  • Stochastic Oscillator
  • TVTX 2.01
  • TRIP 30.92

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About TRIP TripAdvisor Inc.

Tripadvisor is the world's leading travel metasearch company. Its platform offers 1 billion reviews and information on several million accommodations, restaurants, experiences, airlines, and cruises. In 2024, 52% of revenue came from the company's core Brand Tripadvisor segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 46% of sales in 2024, and TheFork, its dining brand, represented 10% of revenue (about 8% of sales were intersegment, which are eliminated from consolidated revenue).

Share on Social Networks: